|Articles|September 30, 2002

BD Ships Smallpox Vaccine Needles Globally

FRANKLIN LAKES, NJ - Syringe and Needle manufacturing giant Becton, Dickinson has begun shipping a specialized needle necessary for administering the smallpox vaccine worldwide.

The FDA-cleared, European CE marked bifurcated needle has two tiny prongs that hold the vaccine. The design was also used by the World Health Organization (WHO) during the smallpox eradication campaign of the 1970s. The BD device, however, is individually sterilized and hard-packaged for safety and biodefense stockpiling needs.

"Since Sept. 11, BD's goal has been to help governments around the world prepare for mass public immunization for smallpox and other life-threatening bioterror agents," says Zeil Rosenberg, BD's worldwide business leader for immunization. "It is critical to have adequate supplies of the bifurcated needle available in the event worldwide immunization for smallpox becomes necessary."

BD officials are also working on advanced information technology platform that will help facilitate such mass immunizations.

For additional information, visit:

www.bd.com

.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.